Literature DB >> 6289703

Five-year longitudinal study of workers employed in a new toluene diisocyanate manufacturing plant.

J E Diem, R N Jones, D J Hendrick, H W Glindmeyer, V Dharmarajan, B T Butcher, J E Salvaggio, H Weill.   

Abstract

The respiratory health of 277 workers in a new toluene diisocyanate (TDI) manufacturing plant was studied prospectively during 5 yr of exposure. Personal TDI monitors were used to continuously measure peak and 8-h time-weighted average (TWA) concentrations in over 2,000 samples. Longitudinal change in pulmonary function was assessed in 223 men in whom 3 or more data points allowed construction of individual slopes of annual change. Regression of annual change on smoking (pack-years), atopic status, and cumulative TDI exposure dichotomized at 68.2 parts per billion (ppb) months into low and high exposure groups showed significant effects of smoking on spirometric tests and lung volumes. After adjusting for pack-years of smoking, the 74 men in the high cumulative TDI exposure category had significantly larger declines in FEV1, %FEV, and FEF25--75% than did the 149 men in the low category. Annual change in FEV1 was then examined in 6 smoking-exposure categories: in never smokers, average annual decline was 38 ml/yr greater in those with higher cumulative TDI exposure. Current and previous cigarette smokers did not show this effect of cumulative TDI exposure. Analysis of FEV1 change by time above 20 ppb TDI yielded a similar result in never smokers, a 24 ml/yr excess average decline attributable to longer time above 20 ppb. In current cigarette smokers, those with longer time above 20 ppb had excess decline of 18 ml/yr (42 versus 24 ml/yr). our low and high cumulative exposure groups spent 2 and 15%, respectively, of their working time above 5 ppb TDI. The different health effects observed in these groups supports the NIOSH-recommended standard of 5 ppb TDI as an 8-h TWA.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6289703     DOI: 10.1164/arrd.1982.126.3.420

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  22 in total

1.  Health information in material safety data sheets for a chemical which causes asthma.

Authors:  L M Frazier; B W Beasley; G K Sharma; A A Mohyuddin
Journal:  J Gen Intern Med       Date:  2001-02       Impact factor: 5.128

2.  Six year follow up of lung function in men occupationally exposed to formaldehyde.

Authors:  A J Nunn; A A Craigen; J H Darbyshire; K M Venables; A J Newman Taylor
Journal:  Br J Ind Med       Date:  1990-11

Review 3.  New aspects of isocyanate asthma.

Authors:  X Baur
Journal:  Lung       Date:  1990       Impact factor: 2.584

4.  Isocyanate-induced asthma: results of inhalation tests with TDI, MDI and methacholine.

Authors:  C Vogelmeier; X Baur; G Fruhmann
Journal:  Int Arch Occup Environ Health       Date:  1991       Impact factor: 3.015

5.  Short-term respiratory changes in polyurethane foam workers exposed to low MDI concentration.

Authors:  F Sulotto; C Romano; G Piolatto; M Coggiola; S Polizzi; C Ciacco; A Berra
Journal:  Int Arch Occup Environ Health       Date:  1990       Impact factor: 3.015

6.  Occupational asthma and alveolitis--unanswered questions.

Authors:  A E Cockcroft
Journal:  J R Soc Med       Date:  1988-05       Impact factor: 5.344

Review 7.  The atopic worker.

Authors:  A I Terr
Journal:  Clin Rev Allergy       Date:  1986-08

8.  Response to Goodman et al.

Authors:  Lynne E Pinkerton; James H Yiin; Robert D Daniels; Kenneth W Fent
Journal:  Am J Ind Med       Date:  2017-02       Impact factor: 2.214

9.  Symptoms and lung function in low-exposure to TDI by polyurethane foam manufacturing.

Authors:  R Alexandersson; G Hedenstierna; E Randma; G Rosen; A Swenson; G Tornling
Journal:  Int Arch Occup Environ Health       Date:  1985       Impact factor: 3.015

10.  Respiratory health surveillance in a toluene di-isocyanate production unit, 1967-97: clinical observations and lung function analyses.

Authors:  M G Ott; J E Klees; S L Poche
Journal:  Occup Environ Med       Date:  2000-01       Impact factor: 4.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.